Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 897 record(s)

Req # A-2023-000994

The Section 1.0.7 “Note to the Reviewer” (Module 1.0.7) from the generic manufacturer of the Estradiol Abbreviated New Drug Submission (ANDS) which appears on the Generic Submissions Under Review (GSUR) List.

Organization: Health Canada

0 page(s)
November 2023

Req # A-2023-000997

Details concerning all proceedings, requests or recourse currently active, underway or pending or any balance owing to you by the company 9226-6709 Québec Inc. (NEQ: 1166807389). Address: 515 l'Avenir St., Québec, QC G1E 5E8.

Organization: Health Canada

0 page(s)
November 2023

Req # A-2023-001044

Obtain details concerning all proceedings, requests or recourse currently active, underway or pending or any balance owing to you by the company. Company: Maison Isabelle inc. (NEQ: 1176226232). 95 Radnor St., Trois-Rivières, QC G8T 2E6.

Organization: Health Canada

0 page(s)
November 2023

Req # A-2023-00300

Information pertaining to the number of arrests in the Maritimes region from 2020 to 2023

Organization: Fisheries and Oceans Canada

0 page(s)
October 2023

Req # A-2023-00718

Information pertaining to a property in Grafton, Ontario

Organization: Fisheries and Oceans Canada

0 page(s)
October 2023

Req # A-2023-00739

Correspondence regarding potential harmful alternation disruption or destruction of fish habitat from July 18, 2023 to September 26, 2023 in relation to the Bradford Bypass (404 to 400 link) in East Gwillimbury and Bradford

Organization: Fisheries and Oceans Canada

0 page(s)
October 2023

Req # A-2023-00797

Documents pertaining to Unindentified Anomalous Phenomena from January 1st, 2000 to October 6th, 2023

Organization: Fisheries and Oceans Canada

0 page(s)
October 2023

Req # A-2023-000821

Information as to whether or not the Abbreviated New Drug Submission (ANDS) for liraglutide accepted into review in August 2017 is on “intellectual property hold” as described in section 6.2 of Health Canada’s Guidance Document on Patented Medicines…

Organization: Health Canada

0 page(s)
October 2023

Req # A-2023-000846

All communications between Health Canada personnel and "Régie de l'assurance maladie du Québec" (RAMQ) personnel that deal with one or more of the following topics: controlled distribution of drugs; notices of compliance with…

Organization: Health Canada

0 page(s)
October 2023

Req # A-2023-000861

All electronic communications within the Public Health Agency of Canada with respect to the Member of Parliament (MP) Michelle Rempel Garner's Substack article entitled "The Public Health Agency of Canada has a trust deficit, and it could…

Organization: Health Canada

0 page(s)
October 2023
Date modified: